Contact

location_on

22 route 128
91190 Gif sur Yvette
France

Nicolas Grandchamp
CSO
call

0153408360

About us

GEG Tech is an independent French deeptech venture specializing in the design of innovative gene transfer solutions for Life Science. We have designed a new generation of nanoparticles combining the advantages of LNPs and viral vectors. These new generations are constituted by a viral packaging enabling a good efficacy and stability, containing non-viral RNA and/or protein conferring a high level of biosafety.

Business offer

The GEG Tech platform offers a unique selection of high-performance nanoparticles for genetic engineering: R&D and therapeutic solutions. DNA-One has unmatched efficacy in a wide range of applications, making it the most powerful vector for a wide range of applications requiring robust gene expression. RNA-One is an unique nanoparticle developed for biomedical applications. RNA-One provides an exceptionally high level of biosafety without compromising its effectiveness and while embarking large payloads with a potential precision targeting function. VLP-One opens new possibilities for applications where biosafety is the primary concern. 

Activities

    Categories

    • Research Unit

    Therapeutic applications

    • Cardiology
    • Genetic Diseases
    • Oncology
    • Nervous Central System
    • Infectiology
    • Immunology
    • Ophthalmology

    Expertises

    Gene and CAR-T cell therapy Directory
    • Gene Cloning
    • Gene augmentation
    • Gene inhibition
    • Killing Gene
    • KI / KO
    • CRISPR activation
    • CRISPR interference
    • TALEN
    • Gene Delivery System
    • Lentivirus
    • CAR Construction
    • Intracellular Domain
    • T-cell activation/transduction
    • Engineering
    • Tandem CAR
    • iCAR
    • Ab-coupled TCR (ATCR)
    • Modulation of CAR potency
    Prophylactic Vaccines Directory
    • Antigen-protective immune-response profile
    • Research exploratory biomarkers
    • efficiency vaccination
    • Vaccine: antigen format platforms
    • Virus-like particles (VLP) and nanoparticle-based carriers
Français English